Professional Breastfeeding Support Intervention
Launched by THE UNIVERSITY OF HONG KONG · Jul 2, 2013
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
The aim of this study is to determine whether early post-partum professional breastfeeding support improves breastfeeding outcomes.
The primary hypotheses are:
1. Exclusive breastfeeding rates at 1, 2, and 3 months will be increased among mother-infant pairs who receive professional lactation support or telephone follow-up support (intervention groups) when compared with those who receive usual post-natal breastfeeding support (control group);
2. The rate of any breastfeeding (predominant or partial) at 1, 2, and 3 months will be increased among mother-infant pairs in the intervention gro...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. delivers at participating trial site,
- • 2. primiparous,
- • 3. intends to breastfeed,
- • 4. 18 years of age or older,
- • 5. has singleton pregnancy,
- • 6. Cantonese speaking,
- • 7. Hong Kong resident for more than one year,
- • 8. no serious medical or obstetrical complications
- Exclusion Criteria:
- • 1. \< 37 weeks gestation,
- • 2. an Apgar score \< 8 at five minutes,
- • 3. a birth weight \< 2500 grams,
- • 4. born with any severe medical conditions or congenital malformations,
- • 5. is placed in the special care nursery for more than 48 hours after delivery,
- • 6. is placed in the intensive care nursery after delivery,
- • 7. not entitled to health benefits in Hong Kong (NEP).
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Marie Tarrant, PhD, MPH, RN
Principal Investigator
The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials